Douglas Heigel - Invuity VP of Operations

VP

Mr. Douglas W. Heigel is a Vice President Operations the Company. He has served as our Vice President of Operations since September 2014. From July 2003 to January 2014, Mr. Heigel served as Vice President of Operations for Solta Medical, a medical aesthetics company which was sold to Valeant Pharmaceuticals in January 2014. In May 2002, Mr. Heigel joined Solta Medical predecessor company, Thermage, as Senior Director of Operations. From October 1995 to February 2002, Mr. Heigel worked for Argonaut Technologies, a life sciences company, first as Director of Manufacturing and then as Vice President of Manufacturing. Prior to Argonaut, Mr. Heigel served in various operational and technical leadership roles in the semiconductor and measurement instrumentation markets since 2014.
Age 55
Tenure 10 years
Phone415-665-2100
Webhttp://www.invuity.com
Heigel received a B.S. in mechanical engineering from Oregon State University.

Invuity Management Efficiency

The company has return on total asset (ROA) of (39.66) % which means that it has lost $39.66 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (481.4) %, meaning that it created substantial loss on money invested by shareholders. Invuity's management efficiency ratios could be used to measure how well Invuity manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 34.66 M in liabilities. Invuity has a current ratio of 2.09, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Invuity until it has trouble settling it off, either with new capital or with free cash flow. So, Invuity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Invuity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Invuity to invest in growth at high rates of return. When we think about Invuity's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

VP Age

Kevin NashGentex
49
Gilbert PassinTesla Inc
51
Jerome GuillenTesla Inc
42
Gregory ReichowTesla Inc
45
Ryan WentlingVisteon Corp
N/A
Richard MansonOlympic Steel
55
Peter ZiparoVisteon Corp
44
Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and is traded on NASDAQ General Markets. It employs 161 people. Invuity (IVTY) is traded on NASDAQ Exchange in USA and employs 161 people.

Management Performance

Invuity Leadership Team

Elected by the shareholders, the Invuity's board of directors comprises two types of representatives: Invuity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Invuity. The board's role is to monitor Invuity's management team and ensure that shareholders' interests are well served. Invuity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Invuity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Gerberich, Vice President - Sales and Marketing
Douglas Heigel, VP of Operations
Daniel Wolterman, Director
Alex Vayser, Co-Founder and CTO
William Burke, Independent Director
Philip Sawyer, CEO and President and Director
Eric Roberts, Independent Director
Andrew Sale, Senior Vice President of Global Sales
Scott Flora, Director
Gregory Brown,
James Mackaness, CFO
Steve Annen, Vice President of Product Management and Strategy
Joseph Guido, Vice President of Business Development
Randall Lipps, Independent Director
Paul Davison, VP of RandD
Reza Zadno, Independent Director
Brett Robertson, Chief Business Officer, General Counsel
Gregory Lucier, Chairman of the Board
Marcia Fish, Chief Human Resource Officer

Invuity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Invuity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Invuity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Invuity's short interest history, or implied volatility extrapolated from Invuity options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Invuity Stock

If you are still planning to invest in Invuity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Invuity's history and understand the potential risks before investing.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules